Breaking News

 Biotech aims to make stem cell transplants outpatient procedures

Not rendering correctly? View this email as a web page here.

How the test-to-treat pillar of the U.S. Covid strategy is failing patients

By Hannah Recht, Kaiser Health News Friday, April 15, 2022 6:54 PM

Large swaths of the country had no test-to-treat pharmacies or health centers listed as of April 14. And the website of the largest participant, CVS, has significant technical issues that make booking an appointment difficult.

Read more »

How vocal biomarkers are becoming a necessary tool for remote patient monitoring

By David Liu Friday, April 15, 2022 1:08 PM

With the information contained in a simple 30-second voice sample, providers can help patients get ahead of future health issues and prescribe or adjust treatment plans as needed.

Read more »

A biotech's bold vision to turn stem cell transplants into outpatient procedures

By Frank Vinluan Friday, April 15, 2022 1:05 PM

Versant Ventures has launched Cimeio Therapeutics, a biotech startup with technology that can shield transplanted stem cells or cell therapies. Shielding these cells enables them to be dosed alongside an immunotherapy—an approach that is not currently done because the therapies don't discriminate between diseased cells and transplanted ones.

Read more »

Nurses union survey finds workplace violence, unsafe working conditions are on the rise

By Michael Schroeder Friday, April 15, 2022 12:55 PM

The survey, released Thursday by National Nurses United, polled 2,575 registered nurses. Hospital RNs also reported that their hospitals are still not adequately prepared for a Covid-19 surge.

Read more »

   

No comments